Recommandations de l'Association des urologues du Canada sur le dépistage et le diagnostic précoce du cancer de la prostate.
作者信息
Rendon Ricardo A, Mason Ross J, Marzouk Karim, Finelli Antonio, Saad Fred, So Alan, Violette Phillipe, Breau Rodney H
机构信息
Département d'urologie, Université Dalhousie, Halifax, N.-É., Canada.
Département d'urologie, Clinique Mayo, Rochester, Minn., États-Unis.
出版信息
Can Urol Assoc J. 2017 Oct;11(10):298-309. doi: 10.5489/cuaj.4888.
Abstract
摘要
相似文献
1
Recommandations de l'Association des urologues du Canada sur le dépistage et le diagnostic précoce du cancer de la prostate.
Can Urol Assoc J. 2017 Oct;11(10):298-309. doi: 10.5489/cuaj.4888.
2
N 385 - Indications de l'examen pelvien.
J Obstet Gynaecol Can. 2019 Aug;41(8):1235-1250. doi: 10.1016/j.jogc.2019.04.003.
3
N 366 - Prise en charge gynécologique du cancer du sein et de l'ovaire héréditaire.
J Obstet Gynaecol Can. 2018 Nov;40(11):1511-1527. doi: 10.1016/j.jogc.2018.09.001.
4
Guide de pratique clinique fondé sur des données probantes pour l'examen périodique de la vue chez les enfants de 0 à 5 ans au Canada.
Can J Ophthalmol. 2019 Dec;54(6):e259-e267. doi: 10.1016/j.jcjo.2019.09.002. Epub 2019 Nov 23.
5
N° 367-2019 Lignes Directrices Canadiennes Sur L'activité Physique Durant La Grossesse.
J Obstet Gynaecol Can. 2018 Nov;40(11):1538-1548. doi: 10.1016/j.jogc.2018.09.003. Epub 2018 Oct 18.
6
Consensus canadien sur la nutrition féminine : adolescence, reproduction, ménopause et au-delà.
J Obstet Gynaecol Can. 2016 Jun;38(6):555-609.e19. doi: 10.1016/j.jogc.2016.05.008.
7
N 369 - Prise en charge de la grossesse aprés une mortinaissance.
J Obstet Gynaecol Can. 2018 Dec;40(12):1684-1700. doi: 10.1016/j.jogc.2018.10.012.
8
Évaluation échographique des complications au premier trimestre de grossesse.
J Obstet Gynaecol Can. 2016 Oct;38(10):989-996. doi: 10.1016/j.jogc.2016.06.002.
9
N 115 - Choc hémorragique.
J Obstet Gynaecol Can. 2018 Dec;40(12):e883-e892. doi: 10.1016/j.jogc.2018.10.005.
10
Développement et implantation d'une intervention ciblée encourageant le dépistage régulier du VIH chez les travailleuses du sexe au Bénin : application du protocole d' intervention mapping.
Glob Health Promot. 2018 Sep;25(3):81-92. doi: 10.1177/1757975916663874. Epub 2016 Oct 7.
引用本文的文献
1
Harmonization of clinical practice guidelines for primary prevention and screening: actionable recommendations and resources for primary care.
BMC Prim Care. 2024 May 6;25(1):153. doi: 10.1186/s12875-024-02388-3.
2
Patient Communication Preferences for Prostate Cancer Screening Discussions: A Scoping Review.
Ann Fam Med. 2023 Sep-Oct;21(5):448-455. doi: 10.1370/afm.3011.
3
Economic evaluation of prostate cancer risk assessment methods: A cost-effectiveness analysis using population data.
Cancer Med. 2023 Oct;12(19):20106-20118. doi: 10.1002/cam4.6587. Epub 2023 Sep 23.
4
Development and External Validation of Partial Proportional Odds Risk Prediction Models for Cancer Stage at Diagnosis among Males and Females in Canada.
Cancers (Basel). 2023 Jul 8;15(14):3545. doi: 10.3390/cancers15143545.
5
High infiltration of CD209 dendritic cells and CD163 macrophages in the peritumor area of prostate cancer is predictive of late adverse outcomes.
Front Immunol. 2023 Jun 26;14:1205266. doi: 10.3389/fimmu.2023.1205266. eCollection 2023.
6
UPDATE - Canadian Urological Association guideline: Male lower urinary tract symptoms/benign prostatic hyperplasia.
Can Urol Assoc J. 2022 Aug;16(8):245-256. doi: 10.5489/cuaj.7906.
7
The impact of health-policy-driven subsidisation of prostate magnetic resonance imaging on transperineal prostate biopsy practice and outcomes.
BJUI Compass. 2022 Feb 11;3(4):304-309. doi: 10.1002/bco2.140. eCollection 2022 Jul.
8
Clash of the calculators: External validation of prostate cancer risk calculators in men undergoing mpMRI and transperineal biopsy.
BJUI Compass. 2021 Mar 3;2(3):194-201. doi: 10.1002/bco2.58. eCollection 2021 May.
9
Prostate Cancer Incidence and Mortality: Global Status and Temporal Trends in 89 Countries From 2000 to 2019.
Front Public Health. 2022 Feb 16;10:811044. doi: 10.3389/fpubh.2022.811044. eCollection 2022.
10
Recommendations on Weight Loss and Healthy Lifestyle in Prostate Cancer Clinical Guidelines: A Systematic Review.
Int J Environ Res Public Health. 2022 Jan 27;19(3):1452. doi: 10.3390/ijerph19031452.
本文引用的文献
1
Evidence-based guideline recommendations on multiparametric magnetic resonance imaging in the diagnosis of prostate cancer: A Cancer Care Ontario clinical practice guideline.
Can Urol Assoc J. 2017 Jan-Feb;11(1-2):E1-E7. doi: 10.5489/cuaj.3968. Epub 2017 Jan 12.
2
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study.
Lancet. 2017 Feb 25;389(10071):815-822. doi: 10.1016/S0140-6736(16)32401-1. Epub 2017 Jan 20.
3
Increase in Prostate Cancer Distant Metastases at Diagnosis in the United States.
JAMA Oncol. 2017 May 1;3(5):705-707. doi: 10.1001/jamaoncol.2016.5465.
4
Extended mortality results for prostate cancer screening in the PLCO trial with median follow-up of 15 years.
Cancer. 2017 Feb 15;123(4):592-599. doi: 10.1002/cncr.30474. Epub 2016 Dec 1.
5
Prostate Health Index improves multivariable risk prediction of aggressive prostate cancer.
BJU Int. 2017 Jul;120(1):61-68. doi: 10.1111/bju.13676. Epub 2016 Nov 22.
6
Properties of the 4-Kallikrein Panel Outside the Diagnostic Gray Zone: Meta-Analysis of Patients with Positive Digital Rectal Examination or Prostate Specific Antigen 10 ng/ml and Above.
J Urol. 2017 Mar;197(3 Pt 1):607-613. doi: 10.1016/j.juro.2016.09.086. Epub 2016 Sep 28.
7
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer.
N Engl J Med. 2016 Oct 13;375(15):1415-1424. doi: 10.1056/NEJMoa1606220. Epub 2016 Sep 14.
8
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.
Eur Urol. 2017 Apr;71(4):618-629. doi: 10.1016/j.eururo.2016.08.003. Epub 2016 Aug 25.
9
Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer.
J Clin Oncol. 2016 Aug 10;34(23):2705-11. doi: 10.1200/JCO.2016.66.7527. Epub 2016 Jun 13.
10
Serial Percent Free Prostate Specific Antigen in Combination with Prostate Specific Antigen for Population Based Early Detection of Prostate Cancer.
J Urol. 2016 Aug;196(2):355-60. doi: 10.1016/j.juro.2016.03.011. Epub 2016 Mar 12.
Zotero 插件